About Manchester Royal Eye Hospital Charity
Manchester Royal Eye
Hospital is one of the largest teaching hospitals in Europe. Globally
acknowledged as a centre of excellence, Manchester Royal Eye Hospital is
renowned for its pioneering work in all aspects of ophthalmology, including
patient care, surgery and education.
The aim of Manchester
Royal Eye Hospital Charity is to support continued excellence in treatment,
care and research to enhance the lives of thousands of patients and their
families each year.
The charity helps to
provide the hospital with leading state-of-the-art equipment so that the
exceptional doctors and nurses can improve diagnosis and treatment and
continue to offer patients world-class care. The charity also support s the
development of more family-friendly spaces within the hospital, to help
patients and their families feel a little more able to relax at what can be
a very difficult time for them. In addition to this the charity also helps
to support early stage research into better ways to understand and treat eye
About Medical Research at the University of
The University of Manchester is one of the UK’s
leading research universities. The results of the 2008 Research Assessment
Exercise, which measures the quality of research conducted in UK
universities, places Manchester in the top three, only behind Oxford and
Our research power
combined with our vital NHS partnerships means we are in the best possible
position to rapidly translate discoveries for the benefit of patients. We
have matched our strengths to areas of exceptional patient need and have
identified genetic medicine as a major priority. Through an expanded
programme of research we will transform our impact for patients locally,
nationally and across the globe.
The University of
Manchester’s history is closely intertwined with the visionary
philanthropists who made its existence possible. Philanthropy today
continues to play a critical role in accelerating our research so together
we can change the future for patients and their families.
Childhood Genetic Eye
University of Manchester and the Manchester Royal Eye Hospital
The University of
Manchester and Manchester Royal Eye Hospital share the same vision to be a
world-leading paediatric centre for genetic diseases to make lives better
for children and their families. This requires both outstanding research AND
a well-equipped and welcoming clinic. The University and the Hospital are
delighted Michael has chosen to jointly support their work in 2014.
Supporting research at
the University of Manchester:
Currently the reality for
families is that inherited eye disease is not cure-able. Professor Black and
his colleagues refuse to accept this for the future. Their Manchester vision
is to accelerate research to bring improvements to patients and families as
quickly as possible.
Their world class
research programme – including improving genetic testing and pioneering new
gene therapies – promises to bring fresh hope for families affected by these
Manchester Eye Hospital:
In 2014 the Manchester
Royal Eye Hospital is marking its 200th anniversary. As part of
this they are seeking support to transform their paediatric ophthalmology
unit. They would like to make the clinic more family friendly and be able
to give more specialist advice, information and assistance to families with
children who have eye problems.
In addition to this they would like to purchase next generation sequencers
and imaging equipment. This equipment will enable genetic testing that can
speed diagnosis for patients suffering from genetic eye disease - from years
to weeks. It will also provide a vital foundation for all research
undertaken by the hospital and the University into eye diseases.
For more information
Press Release from
Manchester Royal Eye Hospital and University of Manchester:
Michael Owen to
raise cash for eye research and treatment in Manchester
Owen has announced he will run the London Marathon to support Manchester
Royal Eye Hospital and scientists from The University of Manchester in their
mission to find new treatments for families with genetic eye disorders.
The former England
striker who played for Liverpool, Real Madrid, Newcastle United, Manchester
United and Stoke City said he hoped his support would help scientists and
doctors develop new treatments for patients with inherited eye disorders –
where currently there is no available cure.
The University of
Manchester, in partnership with the Central Manchester University Hospitals
NHS Foundation Trust which runs Manchester Royal Eye Hospital, is making a
major contribution to the future of genetic medicine through the Manchester
Centre for Genomic Medicine.
Many of these rare
genetic diseases are currently untreatable but Graeme Black, Professor of
Genetics at The University of Manchester and Honorary Consultant in Genetics
at St Marys Hospital Manchester together with Professor Chris Lloyd,
Consultant Paediatric Ophthalmologist at Manchester Royal Eye Hospital
refuse to accept this for the future. They are working hard with their
colleagues to accelerate research in this area and aim to improve treatments
available to patients and families affected by genetic eye diseases. These
include cataracts in young children and blindness caused by inherited
diseases of the retina.
specialised research aims to identify new gene variants that cause disease
in the eye. It will enable doctors and researchers to better understand how
such eye problems develop as well as opening up the possibility of genetic
screening, better and more specific management of eye diseases and the
potential for targeted therapies.
Their research has
already led to improvements for patients and their families. A new test
developed for inherited eye disease has increased diagnostic pick-up rates
from 15% to over 60%.
This year Manchester
Royal Eye Hospital is marking the bicentenary of its foundation and hopes to
raise funds to improve the children’s outpatient clinic, ensuring it is
equipped with the very best diagnostic equipment for children. This
equipment will not only help in diagnosis but also support research into
children’s eye disease.
“We are absolutely
delighted to have Michael's support for the fundraising being undertaken in
this the 200th year of the Manchester Royal Eye Hospital through his run in
the London Marathon”.
Professor Black, who
heads the Manchester Centre for Genomic Medicine, added:
developed an integrated clinical and research team that represents one of
the largest clinical paediatric and eye services in Europe helping us to
advance developments in Genomic Medicine.
We are developing
internationally-recognised gene testing protocols for diagnosis and
exploring the development of new treatments for genetic disorders of the eye
and improving treatments for childhood cataract. We are also improving
participation in world-leading clinical trials.
We have no doubt
that Michael's support will further accelerate these developments.”